Haruo Kawamura
Founding Partner
Get their honest, personalized take on your startup.
Sign in to pitch Haruo →At a glance
- Full Name
- Haruo Kawamura (川村 治夫)
- Title
- Representative Director & Founding Partner, CEO
- Firm
- CAS Capital, Inc. (キャス・キャピタル株式会社)
- Firm Type
- Independent private equity / buyout fund manager (not an angel investor — see Background)
- Investment Stage
- Control buyouts of mature mid-market companies (carve-outs and business-succession deals); not seed/angel
- Check Size
- Targets mid-cap deals of roughly ¥5–50 billion enterprise value per company; latest vehicle (Fund VIII, 2025) closed at ¥20 billion in commitments
- Target Company Profile
- Established mid-sized and small Japanese companies — non-core divisions/subsidiaries carved out of large corporations, and owner-succession situations
- Sector Focus
- Sector-agnostic, but with concentration in food service/manufacturing, healthcare and veterinary/animal medicine, industrial manufacturing, and staffing
- Geographic Focus
- Japan (domestic)
- Location
- Chiyoda-ku, Tokyo, Japan (Parkside House 5F, 2 Ichibancho)
Background
Haruo Kawamura is the founder and CEO of CAS Capital, Inc., an independent Tokyo-based private equity firm he established in March 2003. Before founding the firm, he built a 20-plus-year career in banking and investment banking: he began at the Bank of Tokyo (now MUFG Bank) and went on to serve as a Managing Director in the investment banking divisions of both Goldman Sachs and Morgan Stanley, where he advised corporates and financial institutions on M&A and securities underwriting. Aggregator profiles (Bloomberg/LinkedIn) also list education at The Wharton School, University of Pennsylvania.
He named the firm "CAS" after the English rendering of Shiba Ryōtarō's novel *Clouds Above the Slope* ("Clouds Above the Slope"), reflecting an ambition to be a supportive force behind the growth of Japanese companies. CAS Capital operates as a buyout fund manager, taking majority stakes in established mid-market businesses and providing hands-on operational and management support over a roughly five-year hold, rather than making early-stage venture bets.
Beyond the firm, Kawamura has been active in the Japanese PE ecosystem and academia: he served as a Director of the Japan Private Equity Association (roughly 2015–2022) and was a part-time lecturer at the Tokyo Institute of Technology's Graduate School of Decision Science and Technology (2002–2015).
Note: The supplied stub data labeled Kawamura an "Angel Investor" investing in "Seed Rounds." Research does not support this — CAS Capital is a control-oriented mid-market buyout firm, and Kawamura's activity is in later-stage acquisitions, not angel/seed investing. The contact phone (+81-3-3556-5990) matches the firm's published number.
Investment Thesis & Focus
- Runs a series of institutional buyout funds (Funds I–VIII); Fund VI (2014) closed at ~¥13.5B, Fund VII (2019) at ~¥18.7B, and Fund VIII (2025) at ¥20B.
- Invests in majority control of mature mid-market Japanese companies, typically ¥5–50B in enterprise value per deal.
- Two core deal types: (1) carve-outs of non-core divisions or subsidiaries from large corporations, and (2) business-succession deals where an owner needs a transition (the firm has cited ~18 of 23 deals as succession-related).
- Value creation is hands-on and operationally driven, leveraging in-house SME development and management-consulting know-how, with a long-term (~5-year) holding stance rather than financial engineering alone.
- Explicitly mission-driven: the firm states its aim is to "contribute to build strong companies in Japan."
Notable Investments
- Decollte Holdings — Photo/wedding photography services; IPO in June 2021, with the remaining stake sold to Mixi in September 2022 (a headline exit).
- Kinrei (キンレイ) — Frozen-food maker carved out via MBO from Osaka Gas (2005); sold to ORIX (2012).
- Kazokutei (家族亭) — Japanese casual-dining restaurant chain; acquired ~2007, sold to H2O Retailing (2011).
- Food Plus Holdings — Operator of "Shoya"/"Hyakusai" restaurants and catering; exited to a New Horizons Capital fund (February 2024).
- Mark Tec — Industrial non-destructive testing niche leader; exited to Alconix (2016); a JPEA award-winning case.
- Care Plus / Staff Plus / Saint Staff — Healthcare home-care and medical staffing businesses; exited to ALSOK, Infocom, and Misawa Home respectively.
- Phoenix Associates — Language/skills training; sold to Berlitz (2009).
- Motto Gyutto — Pet insurance; sold to Rakuten (2018).
- Act One Yamaichi — Construction equipment rental; exited to a T Capital Partners fund (2019).
- Animal-medicine platform (current) — ANCHORS / Japan Animal Care Holdings, Vetlead, Japan Animal Advanced Medical Research, Kimata Animal Hospital, North Vets, and Keizan Medical (Nagoya hospitals & nursing school).
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.